Most recent update: Friday, December 8, 2017 - 12:34

Bariatric News - Cookies & privacy policy

You are here

Product approval

FDA clearance for Endoflip with Flip Topography Module

Company claims system will greatly improve the quality of patient experience during swallow testing

Crospon, an endoscopic diagnostics company, has received FDA clearance for its Endoflip System with Flip Topography Module, providing a new way for clinicians to assess patient motility disorders during endoscopy. This next generation of the Endoflip System, Endoflip 2.0, introduces imaging software that displays real-time oesophageal contractility patterns on a 24-inch touch-screen.

Endoflip 2.0 system

“This clearance represents a significant milestone for our organisation as we can now offer physicians an additional tool that can be used during endoscopy, along with other diagnostic methods, to evaluate patients with symptoms consistent with gastrointestinal motility disorders”, said John O’Dea, CEO and founder of Crospon. “The stand out benefit of this application, for both patients and caregivers, is that the Flip Topography assessment can be performed in less than five minutes during upper endoscopy on a sedated patient. In addition to significantly reducing discomfort, the patient may not have to wait for testing at a specialised center, thereby reducing their time to treatment. While not always a substitute for manometry, Endoflip 2.0 can reveal situations of non-obstructive dysphagia which may benefit from further evaluation from manometry.”

The repetitive visual cues of the patented Endoflip technology enables gastroenterologists, for the first time, to investigate for conditions such as achalasia, gastroesophageal junction outflow obstruction and other major or minor disorders of peristalsis during endoscopy. EndoFLIP 2.0 also introduces the new capability to capture and store Endoflip images in electronic patient records.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.